Nasdaq
$1.60▲ 5.96%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $56.2MShares out 35.1M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
22- 10.14After-hours26.10.15 06:41SCHEDULE 13GOwnership#●●●
Skye Bioscience, Inc.
Tang Capital Management and its affiliated entities have filed a Schedule 13G to report their joint beneficial ownership of Skye Bioscience, Inc. common stock. This filing formalizes the collective holding of shares by the entities managed by Kevin Tang.…more
$1.60+5.96%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 9.24After-hours26.09.25 05:314Ownership
Skye Bioscience, Inc.
Insider Andrew J. Schwab of Skye Bioscience, Inc. filed a Form 4 report on September 24, 2026, regarding changes in beneficial ownership of securities as of September 22, 2026.…more
$1.60+5.96%vs prev closeView filingShare - 9.24After-hours26.09.25 05:30SCHEDULE 13D/AOwnership
Skye Bioscience, Inc.
5AM Partners VII, LLC has filed a SCHEDULE 13D/A regarding its beneficial ownership in Skye Bioscience, Inc. This filing serves to update the status of the investor's equity holdings in the company.…more
$1.60+5.96%vs prev closeView filingShare
21 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 9.11After-hours26.09.12 05:16#●●●
Skye Bioscience CFO Resigns; CEO Punit Dhillon To Assume Financial Oversight…more
Skye Bioscience announced that CFO John Sharp will resign effective September 8, with CEO Punit Dhillon taking over as the principal financial and accounting officer. This sudden leadership change in the finance department may introduce uncertainty for investors.…more
$1.60+5.96%vs prev closeDetected5m · 30m · 60m · Next dayPLUSShareBenzinga
- 8.24After-hours26.08.25 05:06
●●●●●●●● ●●●●● ●●●●●●
Skye Bioscience has entered into a securities purchase agreement with an affiliate of Redmile Group to raise up to $22 million. The final funding amount is subject to adjustments based on the proceeds from the company's concurrent PIPE financing.…more
$1.60+5.96%vs prev closeShareBenzinga - 8.21After-hours26.08.22 08:50
●●●●●●●● ●●●●● ●●●●●●
Trading of Skye Bioscience shares has been temporarily halted pending the release of significant news. Investors should monitor for upcoming announcements that may impact the stock price.…more
$1.60+5.96%vs prev closeShareBenzinga
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report